Skip to main content
  • linkedin
New Website Coming Soon!
Hit enter to search or ESC to close
Close Search
Hepion PharmaceuticalsHepion Pharmaceuticals
Menu
  • About
    • Company Overview
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnering
  • Liver Disease
    • Overview
    • Non-alcoholic Steatohepatitis (NASH)
    • Hepatocellular Carcinoma (HCC)
    • Viral Hepatitis
  • AI-POWR™
  • Pipeline
    • Overview
    • Rencofilstat
    • Therapeutic Strategy
    • Clinical Trials
    • Publications
    • Expanded Access Policy
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
    Hepion Pharmaceuticals
    Media Placements

    Hepion Pharmaceuticals’ Lead Therapy, Rencofilstat [Oncology Tube]

    By HepionAugust 8, 2022No Comments

    Hepion Pharmaceuticals’ Lead Therapy, Rencofilstat [Oncology Tube]

    https://oncologytube.com/v/41256#gsc.tab=0
    Share
    Share Share Share Pin
    Get Important News and Updates by Email Subscribe
    • linkedin

    © 2026 Hepion Pharmaceuticals | Disclaimer & Terms of Use | WDDI

    Close Menu
    • About
      • Company Overview
      • Executive Team
      • Board of Directors
      • Scientific Advisory Board
      • Partnering
    • Liver Disease
      • Overview
      • Non-alcoholic Steatohepatitis (NASH)
      • Hepatocellular Carcinoma (HCC)
      • Viral Hepatitis
    • AI-POWR™
    • Pipeline
      • Overview
      • Rencofilstat
      • Therapeutic Strategy
      • Clinical Trials
      • Publications
      • Expanded Access Policy
    • Newsroom
    • Investors
      • Investor Overview
      • Press Releases
      • Events
      • Presentations
      • Company Information
      • Stock Information
      • SEC Filings
      • Corporate Governance
    • Contact
      • Contact Us
      • Careers
    • linkedin